Here are 16 key notes on orthopedic and spine device companies from the past week.
Stryker CEO Kevin Lobo and Vice President of Strategy and Investor Relations Katherine Owen discussed the device company's better-than-
expected performance for the Mako surgical robotic line and concerns about the spine line going forward during the quarterly investors call.
Smith & Nephew reported 2017 revenue of $4.7 billion, a 2 percent increase over 2016.
Zimmer Biomet received a Form 483 from the FDA that cited eight issues following a 10-day in inspection in October 2017.
Medtronic hired Gregory Zimprich to serve as the director of finance communications.
Smith & Nephew's CEO Olivier Bohuon spoke on a range of topics during the company's quarterly earnings call, discussing 2017 results as well as
the potential for growth in 2018.
NuVasive named John DeFord, PhD, to its board of directors.
Zimmer Biomet celebrated two decades of its Rapid Recovery program in Europe.
OrthoXel received FDA 510(k) clearance and CE mark approval for their Apex Tibial Nailing System.
Ceterix Orthopaedics completed enrollment in a study of suture-based horizontal meniscal tear repair. The study is the first prospective multicenter
investigation of suture-based repair for patients with this common knee injury.
InVivo Therapeutics named Richard Toselli, MD, permanent CEO and president. He had been serving as acting CEO since December 2017.
Aurora Spine upsized its non-brokered private placement offering of common shares, due to investor demand.
ChoiceSpine named Stephen Ainsworth, PhD, executive vice president of strategy and technology and Kurt Kessler vice president of sales.
Orthofix International received FDA clearance for its Forza XP Expandable Spacer System.
Lumere named Chicago-based orthopedic surgeon John Cherf, MD, as the company's first CMO.
Simplify Medical ended a second tranche of its Series B financing, totaling $44.3 million.
Surgeons performed the first procedures using Camber Spine's SPIRA-C Open Matrix Cervical Interbody device.